All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy.

Song, Sukyung; Shim, Man Kyu; Yang, Suah; Lee, Jaewan; Yun, Wan Su; Cho, Hanhee; Moon, Yujeong; Min, Jin Young; Han, Eun Hee; Yoon, Hong Yeol; Kim, Kwangmeyung

Song, Sukyung; Shim, Man Kyu; Yang, Suah; Lee, Jaewan; Yun, Wan Su; Cho, Hanhee; Moon, Yujeong; Min, Jin Young; Han, Eun Hee; Yoon, Hong Yeol; Kim, Kwangmeyung.

Afiliação

Song S; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
Shim MK; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Yang S; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Lee J; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Yun WS; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
Cho H; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Moon Y; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
Min JY; College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
Han EH; Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, 02792, Republic of Korea.
Yoon HY; Department of Bioengineering, Korea University, Seoul, 02841, Republic of Korea.
Kim K; Research Center for Bioconvergence Analysis, Korea Basic Science Institute (KBSI), Cheongju, 28119, Republic of Korea.